Prostate cancer drug breakthrough NXP800 offers new hope for patients facing treatment resistance
The drug, known as NXP800, works by targeting the heat shock factor 1 (HSF1) pathway, a cellular protective mechanism that is ...
Science Daily16m
New AI platform identifies which patients are likely to benefit most from a clinical trial
A new study demonstrates that a first-of-its-kind platform using artificial intelligence (AI) could help clinicians and patients assess whether and how much an individual patient may benefit from a ...